Launch of Gastric Cancer Screening Kit

 

 

We are happy to announce that we are launching a new product—GC-REAAD™, an ELISA-based gastric cancer screening kit today.

Restalyst GC-REAAD™ is an ELISA test that has demonstrated sensitivity and specificity rates of between 80-95% when validated with samples from gastric cancer patients. These rates demonstrated higher accuracy rates for diagnosing gastric cancer as compared to other generic gastric cancer screening tests. Also, GC-REAAD has successfully attained the CE Mark certification.

 

GC-REAAD™ will be launched at Restalyst’s booth in MEDICA2015, which is located at Hall 3, Booth 74, as part of the Singapore Pavilion. 

 

If you would like to know more about GC-REAAD™, do drop us an email at This email address is being protected from spambots. You need JavaScript enabled to view it. or make an appointment to meet us at MEDICA2015.